NEWS
BRITISH TECHNOLOGY COMPANY IS SELECTED BY THE WHITE HOUSE-BACKED ACCELERATOR PROGRAMME TO HALF CANCER DEATHS
C
the Signs , a British AI technology company founded by NHS Doctors at the forefront of early cancer detection , has been announced as part of the inaugural cohort of the White House CancerX Accelerator programme .
CancerX was unveiled by the White House in a landmark announcement last year to spearhead innovation in oncology . The initiative aims to achieve the ambitious ‘ Cancer Moonshot ’ goals set by the administration : to reduce cancer mortality by at least 50 % over the next 25 years , and to enhance the quality of life for individuals and families living with and surviving cancer . The CancerX Accelerator programme aims to promote and fortify digital innovations in oncology by providing promising startups an opportunity to collaborate with leading cancer organisations .
C the Signs is an AI cancer prediction platform that identifies patients at risk of cancer at the earliest and most curable stage of the disease . It has so far detected over 25,000 patients with cancer through its innovative AI approach , with a 98 % accuracy in ruling in or out cancer risk . It was selected as one of 16 companies – and the only British company – to be part of the first CancerX Accelerator , C the Signs was selected as it represents one of the most progressive and effective ways of driving digital innovation in oncology .
Dr Bea Bakshi , CEO and Co-founder of C the Signs , said : “ As a doctor , I am deeply moved and profoundly grateful for our selection to participate in the inaugural CancerX accelerator . Launched by the White House , this initiative marks a significant step toward realizing the Cancer Moonshot ’ s vision of a 50 % reduction in cancer mortality . At C the Signs , our mission is firmly rooted in the belief that early detection can change the course of this disease , aiming for a future where surviving cancer is the norm rather than the exception .”
THOUGHT LEADERS CONVERGE AT NATIONAL HEALTH COUNCIL LEADERSHIP CONFERENCE TO ADVANCE CARE FOR PATIENTS discuss and evaluate emerging issues in health care policy .
“ The NHC ’ s mission is to bring diverse organisations together to forge consensus and drive patient-centred health policy ,” said Jeff Todd , President and CEO of Prevent Blindness , and Chair of the National Health Council Board of Directors . “ On topics such as Artificial Intelligence and ‘ the new normal ’ in healthcare , attendees are collaborating to create the next generation of firstclass , patient-centred care .”
“ The NHC Health Leadership Conference serves as a laboratory for new ideas and new ways of doing things on the road to a brighter health care future , that is completely accessible , more affordable , and entirely equitable ,” added Randall L . Rutta , CEO of the NHC .
“ The NHC is proud to play a key role in bringing together so many talented leaders to collaborate and innovate on behalf of the health care system and the patients it serves .” �
Senior leaders – CEOs , Senior Executives and Board leaders – from the nation ’ s ( US ) top Patient Organisations and Partners of Patient Organisations , are coming together at the National Health Council ( NHC ) 2024 Health Leadership Conference , entitled : ‘ The Urgency of Now : Think Patient ’, to
12 www . intelligenthealth . tech